AI-generated summary
The authors report a clinical trial comparing transcranial laser photobiomodulation plus neuromuscular electrical stimulation with a placebo laser plus stimulation in hemiplegic stroke patients, reporting improved cognitive function, pain relief and manual dexterity in the treated group. They also describe an ex vivo study of light penetration through cadaver crania. The authors conclude the combination may be a useful rehabilitation resource, but the abstract gives no statistical detail.
- Who or what was studied
- Post-stroke hemiplegic patients (clinical trial); cadavers (ex vivo study)
- Wavelengths
- 660, 808, 980 nm
- Limits stated in the abstract
- The abstract reports no sample size, statistical results or control details beyond a placebo laser group, so the strength of the findings cannot be judged.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm, 980 nm
- Power
- 720 mW
- Total energy
- 43.2 J, 648 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Stroke, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.